- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterMonday, June 5, 2006
 |
OncoLink coverage of the Annual Meeting of the American Society of Clinical Oncology, June 2-6, 2006, in Atlanta, GA OncoLink reporters provide in-depth, up-to-the-minute coverage of sessions and presentations.
|
Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831
Presenter: M.Y. Halyard Presenter's Affiliation: Mayo Clinic, Rochester, MN Type of Session: Scientific Background Breast cancer affects more than 200,000 American women every year and is responsible for 40,000 deaths. Some of the... |
|
|
Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5FU/cisplatin (FP) as first line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results.
Presenter: Y. KangPresenter's Affiliation: Asan Medical Center, Seoul, KoreaType of Session: ScientificBackground Capecitabine is an oral fluropyrimidine with proven efficacy and favorable safety in metastatic colorectal cancer. Because... |
|
|
Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781
Presenter: Tepper JEPresenter's Affiliation: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NCType of Session: ScientificBackground There is disagreement regarding the proper treatment of resectable esophageal carcinoma The... |
|
|
The study of tamoxifen and raloxifene (STAR): Initial findings from the NSABP P-2 breast cancer prevention study
Presenter: D. L. WickerhamPresenter's Affiliation: National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PAType of Session: PlenaryBackground The NSABP-P1 study demonstrated that tamoxifen given to high-risk pre- and post-menopausal... |
|
|
The Women's Health Initiative randomized trial of calcium plus vitamin D: Effects on breast cancer and arthralgias.
Presenter: R. T. ChlebowskiPresenter's Affiliation: Los Angeles Biomedical Research Institute, Torrance, CAType of Session: PlenaryBackground In 12 of 16 retrospective observational studies, calcium (Ca) and vitamin D (D) have been associated... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
